Subcutaneous infliximab in the treatment of patients with perianal fistulizing Crohn’s disease: current evidence and emerging roles
Therapeutic Advances in Gastroenterology
Published online on July 21, 2026
Abstract
Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Perianal fistulizing Crohn’s disease (pfCD), a frequent and serious manifestation of Crohn’s disease (CD), is characterized by perianal inflammation and fistula formation and severely impacts patient quality of life. Due to its complex and progressive ...
Perianal fistulizing Crohn’s disease (pfCD), a frequent and serious manifestation of Crohn’s disease (CD), is characterized by perianal inflammation and fistula formation and severely impacts patient quality of life. Due to its complex and progressive ...